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Introduction
Juvenile dermatomyositis (JDM) is a rare multisystem dis-
order that predominantly affects skeletal muscles and skin
and less frequently the gastrointestinal tract, myocardium,
joints and lungs.
Objectives
To describe the main epidemiological, clinical and analyti-
cal features and outcome of children with JDM followed
in our Pediatric Rheumatology Unit.
Methods
Retrospective review of the clinical records of patients
with JDM attending our centre since January 2004.
Results
Seven patients were included, five of them were females.
The median age at diagnosis was 10 years (range 4 –
17 years) and the median duration of signs and symp-
toms was 7 months (range 2 weeks – 2 years). All
patients had skin alterations at presentation, which
included gottron papules (6/7), heliotrope rash (4/7),
raynaud phenomenon (2/7), livedo reticularis (1/7) and
vasculitis (1/7). Common initial manifestations were also
muscle weakness (5/7), myalgia (5/7), constitutional
symptoms (5/7), arthralgia (5/7) and arthritis (4/7).
One patient presented with cutaneous calcinosis, another
one had esophageal involvement and presented with
dysphagia and dysphonia. All patients had elevated serum
muscle enzymes, four had positivity for antinuclear antibo-
dies and one for rheumatoid factor. Electromyography was
done in all patients and was abnormal in five of them;
muscle biopsy was done in two patients, cutaneous biopsy
in one and magnetic resonance imaging in two, and the
results showed changes compatible with dermatomyositis.
All patients were initially treated with corticosteroids
(n=7), to which it was added, alone or in combination:
methotrexate (n= 5), hydroxychloroquine (n=2), azathiopr-
ine (n=1) and intravenous immunoglobulin (n=1).
The median follow-up time was 4 years (range 4 months –
10 years). One patient developed interstitial lung disease
and another one had salivary calcinosis with parotiditis.
One patient attained prolonged remission off medication
after two years, five patients achieved remission on treat-
ment in a median time of 2 years (range 4 months –
2 years), and one patient had partial response.
Conclusion
Although this is a small series it indicates that, if diag-
nosed early and treated adequately, JDM has a good out-
come. The most frequent initial manifestations were
cutaneous, musculoskeletal and constitutional. During
follow-up one patient had gastrointestinal involvement,
one developed pulmonary manifestations and other one
had salivary calcinosis. Overall there were few complica-
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